Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Current Assets (2016 - 2025)

Historic Current Assets for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $10.7 million.

  • Nephros' Current Assets rose 4554.11% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 4554.11%. This contributed to the annual value of $8.3 million for FY2024, which is 127.31% down from last year.
  • According to the latest figures from Q3 2025, Nephros' Current Assets is $10.7 million, which was up 4554.11% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, Nephros' Current Assets peaked at $14.8 million during Q2 2021, and registered a low of $7.4 million during Q3 2024.
  • Moreover, its 5-year median value for Current Assets was $9.0 million (2025), whereas its average is $10.1 million.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 3940.88% in 2022, then soared by 4554.11% in 2025.
  • Quarter analysis of 5 years shows Nephros' Current Assets stood at $13.6 million in 2021, then plummeted by 39.41% to $8.3 million in 2022, then rose by 1.74% to $8.4 million in 2023, then fell by 1.27% to $8.3 million in 2024, then grew by 29.02% to $10.7 million in 2025.
  • Its Current Assets stands at $10.7 million for Q3 2025, versus $9.6 million for Q2 2025 and $9.0 million for Q1 2025.